US 7,696,182 for CorMedix of Bridgewater, NJ

CorMedix, one of the smaller pharmas of Bridgewater, NJ, obtained U.S. Patent No. 7,696,182, which claims cover the use of Neutrolin® for preventing infection and clotting in hemodialysis catheters. Neutrolin® is an antimicrobial/anticoagulant liquid, comprising taurolidine, that “locks” a patient’s chronic central venous catheter between hemodialysis sessions to keep it free of CRBI and clotting.